Pathogen-Inactivated Platelets Entering Routine use (PIPER): A Prospective, Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Clinical Trial Grant
Administered By
Pathology
Awarded By
Cerus Corporation
Start Date
April 11, 2017
End Date
September 30, 2020
Administered By
Pathology
Awarded By
Cerus Corporation
Start Date
April 11, 2017
End Date
September 30, 2020